Position in EOLS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$106,641
-$195,939 QoQ
Shares Held
25,947
-43.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $466,534,849 across 39 Drug Manufacturers - Specialty & Generic names. EOLS ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
5,650,393 | $135,213,903 | |
| 2 | ZTS |
Zoetis Inc.
|
667,165 | $78,865,573 | |
| 3 | VTRS |
Viatris Inc
|
3,720,915 | $50,269,560 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,182,751 | $35,624,459 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
235,251 | $30,991,966 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
28,421 | $16,853,083 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
284,005 | $13,674,840 | |
| 8 | HLN |
Haleon plc
|
1,285,485 | $12,867,704 |
All Filings in EOLS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,641 | 25,947 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $302,580 | 45,501 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $296,757 | 48,332 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $448,305 | 48,676 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $576,175 | 47,895 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $537,946 | 48,727 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $790,333 | 48,786 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $366,751 | 33,802 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $430,948 | 30,782 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $399,412 | 37,931 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $314,077 | 34,363 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $196,224 | 26,991 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $228,343 | 26,991 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $193,524 | 25,769 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $189,190 | 23,502 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $727,702 | 62,733 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $250,879 | 22,360 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $135,700 | 20,845 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $126,423 | 16,591 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $166,600 | 13,170 | Shares | Sole | 2021-08-06 | |
| 2020-12-31 | $49,801 | 14,822 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $50,173 | 12,832 | Shares | Sole | 2020-12-04 | |
| 2020-06-30 | $68,009 | 12,832 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||